Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 161-168

  Hopkins, Peter M ^a   Plit, Marshall L ^a   Carter, Ian W ^b   Chhajed, Prashant N ^a   Malouf, Monique A ^a   Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CEFEPIME; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; STEROID; TOBRAMYCIN; VANCOMYCIN;

ADENOVIRUS; ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLITIS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; FLU LIKE SYNDROME; FLUORESCENT ANTIBODY TECHNIQUE; FORCED EXPIRATORY VOLUME; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; LUNG TRANSPLANTATION; MALE; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RECIPIENT; RELIABILITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIVITY ANALYSIS; SEROLOGY; THROAT CULTURE; VIRUS CULTURE; VIRUS DETECTION;

ADOLESCENT; ADULT; BRONCHIOLITIS OBLITERANS; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NASOPHARYNX; PHARYNX; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0037316440     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00467-9     Document Type: Article

References (23)

1. Apalsch A.M., Green M., Ledesma-Medina J., Nour B., Wald E.R. Parainfluenza and influenza virus infections in paediatric organ transplant recipients. Clin Infect Dis. 20:1995;394-399.
2. Matar L.D., McAdams H.P., Palmer S.M., et al. Respiratory viral infections in lung transplant recipients Radiologic findings with clinical correlation. Radiology. 213:1999;735-742.
3. Wendt C.H. Community respiratory viruses Organ transplant recipients. Am J Med. 102:1997;31-36.
4. Report on the Bartels Viral Respiratory Screening and Identification Kit. Publication no. 3450-0185E. 1995;Intracel Corp, Issaquah, WA.
5. Palmer S.M., Nancy M.D., Henshaw G., et al. Community respiratory viral infection in adult lung transplant recipients. Chest. 113:1998;944-951.
6. Liu C. Rapid diagnosis of human influenza infection from nasalsmears by means of fluorescein-labelled antibody. Proc Soc Exp Biol Med. 92:1956;883-887.
7. Mackie P.L., Joannidis P.A., Beattie J. Evaluation of an acute point of caresystem screening for respiratory syncytial virus infection. J Hosp Infect. 48:2001;66-71.
8. Rolston K., Englund J.A., Henrickson K., et al. Symposium on respiratory viral infections/discussion. Am J Med. 102:1997;53-54.
9. Lennette E.H., Balows A., Hausler W.J., Shadomy H.J. Manual of clinical microbiology. 4th ed:1995;American Society of Microbiology, Washington DC.
10. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the working formulation for the classification of pulmonary allograft rejection Lung rejection study group. J Heart Lung Transplant. 15:1996;1-15.
11. Holt N.D., Gould F.K., Taylor C.E., et al. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. J Heart Lung Transplant. 16:1997;416-419.
12. Ljungman P., Gleaves C.A., Meyers J.D. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant. 4:1989;35-40.
13. Bowden R.A. Respiratory virus infections after marrow transplant The Fred Hutchinson Cancer Research Center experience. Am J Med. 102:1997;27-30.
14. Garantziotis S., Howell D.N., McAdams H.P., Davis R.D., Henshaw N.G., Palmer S.M. Influenza pneumonia in lung transplant recipients Clinical features and association with bronchiolitis obliterans syndrome. Chest. 119:2001;1277-1280.
15. Fraser R.S., Muller N.L., Colman N., Pare P.D. Diagnosis of diseases of the chest. 4th ed:1999;W. B. Saunders, London.
16. Hayden F.G., Osterhaus A.D.M.E., Treanor J.J., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. N Engl J Med. 337:1997;874-880.
17. McClellan K., Perry C.M. Oseltamivir A review of its use in influenza. Drugs. 61:2001;263-283.
18. Kimball P., Verbeke S., Flattery M., Rhodes C., Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation. 69:2000;2449-2451.
19. Admon D., Engelhard D., Strauss N., Goldman N., Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine. 15:1997;1518-1522.
20. Hohlfeld J., Niedermeyer J., Hamm H., Schafers H.J., Wagner T.O.F., Fabel H. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant. 15:1996;888-894.
21. Faul J.L., Akindipe O.A., Berry G.J., Theodore J. Influenza pneumonia in a pediatric lung transplant recipient. Transplant Int. 13:2000;79-81.
22. Winter J.B., Gouw A.S.H., Groen M., Wildevuur C., Prop J. Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. Transplantation. 57:1994;418-422.
23. Rubin E., Farber J.L. Pathology. 3rd ed:1998;Lippincott-Raven, Philadelphia.